Belite Bio Revenue

Revenue (ttm)

n/a

Revenue Growth

n/a

P/S Ratio

n/a

Revenue / Employee

n/a

Employees

Market Cap

1.50B USD

Revenue Chart

Revenue History

Fiscal Year End	Change	Growth
Dec 31, 2023	-	-
Dec 31, 2022	-	-
Dec 31, 2021	-	-
Dec 31, 2020	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

BLTE News

5 weeks ago - Belite Bio Receives Sakigake (Pioneer Drug) Designation of Tinlarebant for Stargardt Disease in Japan - GlobeNewsWire
2 months ago - Belite Bio to Participate in the Benchmark's 4th Annual Healthcare House Call Investor Conference - GlobeNewsWire
2 months ago - Belite Bio Reports First-Quarter 2024 Financial Results and Provides Corporate Update - GlobeNewsWire
2 months ago - Belite Bio to Participate in the H.C. Wainwright 2nd Annual BioConnect Investor Conference - GlobeNewsWire
2 months ago - Belite Bio to Host Webcast on May 14, 2024, to Discuss First Quarter 2024 Financial Results - GlobeNewsWire
2 months ago - Belite Bio to Participate in Key Opinion Leader Webinar to Discuss Unmet Needs In Stargardt Disease (STGD1) and Geographic Atrophy (GA) and Perspectives On Tinlarebant - GlobeNewsWire
2 months ago - Belite Bio Presents Additional Analysis from Phase 2 Study of Tinlarebant in Stargardt Disease at the ARVO Annual Meeting - GlobeNewsWire
2 months ago - Belite Bio Announces Presentation at the Association for Research in Vision and Ophthalmology 2024 Annual Meeting - GlobeNewsWire

More News